About
Emily Weiss holds a PhD in microbiology, genomics, and plant genetics with expertise in sequencing, screening, and computational analysis. She previously worked at Illumina and DuPont and has published research in Nature Microbiology and eLife; at Ditto Biosciences, she leads platform development for parasite-derived therapeutic engineering.
Emily Weiss, PhD @emilycpierce
We found a parasite molecule that binds a major autoimmune target in the single-digit nM range. Even crazier, it ALSO hits another, completely unrelated immune regulator! It's a natural bispecific π€© Massive thanks to @adaptyvbio for testing out our weird proteins. Letβs go !! https://t.co/xqxx8KxbBL
Feb 13, 2026 Β· β₯ 21 Β· β 6
Emily Weiss, PhD @emilycpierce
Huge thanks also to @sxmawl @ishandeveloper for letting us use @usecardboard to make our video. Check it out!
Feb 9, 2026 Β· β₯ 5
Emily Weiss, PhD @emilycpierce
The world's best immunologists live inside you ππ¦ πͺ± π Watch our launch video to learn more! Thanks to everyone who's believed in @dittobio, especially @agupta @ycombinator ! https://t.co/CTOOmji4Hf
Feb 9, 2026 Β· β₯ 10 Β· β 2
Founder at Ditto BiosciencesYC W26
Intro paths
Emily went through Y Combinator (Winter 2026) β any YC alum in your network can reach them through the YC community.
Their group partner at YC was Ankit Gupta, General Partner at Y Combinator β the partner who ran Ditto Biosciences's batch and knows the company first-hand. YC profile β
In turn, Emily can intro founders to Ditto Biosciences's investors below.
Ditto Biosciences's investors Β· 1
Co-founders at Ditto Biosciences
